Home
>
National Drug Code (NDC)
>
Irinotecan Hydrochloride
Irinotecan Hydrochloride - 61703-349-36 - (Irinotecan Hydrochloride)
Drug Information of Irinotecan Hydrochloride
| Product NDC: | 61703-349 |
| Proprietary Name: | Irinotecan Hydrochloride |
| Non Proprietary Name: | Irinotecan Hydrochloride |
| Active Ingredient(s): | 20 mg/mL & nbsp; Irinotecan Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Irinotecan Hydrochloride
| Product NDC: | 61703-349 |
| Labeler Name: | Hospira Worldwide, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077915 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120416 |
Package Information of Irinotecan Hydrochloride
| Package NDC: | 61703-349-36 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (61703-349-36) > 25 mL in 1 VIAL, SINGLE-USE |
NDC Information of Irinotecan Hydrochloride
| NDC Code | 61703-349-36 |
| Proprietary Name | Irinotecan Hydrochloride |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (61703-349-36) > 25 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 61703-349 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Irinotecan Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120416 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira Worldwide, Inc. |
| Substance Name | IRINOTECAN HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
